Ubiquitination and Degradation of Neuronal Nitric-Oxide Synthase in Vitro: Dimer Stabilization Protects the Enzyme from Proteolysis
- 1 January 2004
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 66 (4) , 964-969
- https://doi.org/10.1124/mol.104.000125
Abstract
It is established that neuronal NO synthase (nNOS) is ubiquitinated and proteasomally degraded. The metabolism-based inactivation of nNOS and the inhibition of heat shock protein 90 (hsp90)-based chaperones, which are known to regulate nNOS, both lead to enhanced proteasomal degradation of nNOS. The mechanism of this selective proteolytic degradation, or in essence how the nNOS becomes labilized and recognized for ubiquitination and subsequent degradation, has not been determined. In the current study, we used a crude preparation of reticulocyte proteins, which contains ubiquitin-conjugating enzymes and the proteasome, to determine how nNOS is labilized. We found that the inactive monomeric heme-deficient nNOS (apo-nNOS) is rapidly degraded in vitro, consistent with the finding that both metabolism-based inactivation and inhibition of hsp90-based chaperones cause the formation of apo-nNOS and enhance its degradation in vivo. In the current study, we discovered that destabilization of the dimeric nNOS, as determined by measuring the SDS-resistant dimer, is sufficient to trigger ubiquitin-proteasomal degradation. Treatment of nNOS with NG-nitro-l-arginine or 7-nitroindazole led to stabilization of the dimeric nNOS and decreased proteasomal degradation of the enzyme, consistent with that observed in cells. Thus, it seems that the dimeric structure is a major determinant of nNOS stability and proteolysis.Keywords
This publication has 24 references indexed in Scilit:
- Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic InterventionThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Distinct Dimer Interaction and Regulation in Nitric-oxide Synthase Types I, II, and IIIJournal of Biological Chemistry, 2002
- Alteration of the Heme Prosthetic Group of Neuronal Nitric-Oxide Synthase during Inactivation byNG-Amino-l-arginine in Vitro and in VivoMolecular Pharmacology, 2002
- hsp90 Is Required for Heme Binding and Activation of Apo-Neuronal Nitric-oxide SynthaseJournal of Biological Chemistry, 2002
- Ubiquitination of Neuronal Nitric-oxide Synthase in Vitro and in VivoJournal of Biological Chemistry, 2000
- Aminoguanidine-mediated Inactivation and Alteration of Neuronal Nitric-oxide SynthasePublished by Elsevier ,2000
- Neuronal Nitric-oxide Synthase Is Regulated by the hsp90-based Chaperone System in VivoPublished by Elsevier ,1999
- Degradation Signal Masking by Heterodimerization of MATα2 and MATa1 Blocks Their Mutual Destruction by the Ubiquitin-Proteasome PathwayCell, 1998
- Determination of nitric oxide synthase cofactors: Heme, FAD, FMN, and tetrahydrobiopterinPublished by Elsevier ,1996
- Differential Effects of Ubiquitin Aldehyde on Ubiquitin and ATP-Dependent Protein DegradationBiochemistry, 1996